The impact of COVID-19 on society and economy is unparalleled. Clinical trials have become more complex and are increasingly being managed remotely, with the emphasis on patient safety and the need to make the patient the center of the study, moving away from sites.Clinion, is a pioneer in solutions supporting decentralized, real-time clinical trial data collection, has developed new and innovative solutions to strengthen decentralized and hybrid clinical trials.
Our BYOD ePRO (electronic Patient Reported Outcomes) experience for patients helped improve compliance and simplify patient participation in clinical trials, allowing CROs and sponsors to conduct clinical trials remotely using their own iOS and Android devices. Since it collects patient data at source and syncs it instantly to the EDC, it allows investigators to monitor patient progress remotely and has helped studies recruit large number of participants from remote locations with very low dropout rates.
In the past quarter, apart from having the opportunity to partner with Bharat Biotech and HCL Technologies, we were honoured to be associated with four other contract research organizations, helping them in the automation and remote conduct of their clinical trials .
The past quarter has been very busy at Quadone with Clinion being engaged in over 30 Covid-19 studies and over 7 vaccine studies being conducted across the world including India, US and Canada. We at Quadone are proud of our contribution in helping fight Covid-19.